Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

C R Bard Inc (NYSE:BCR)

228.96
Delayed Data
As of 4:02pm ET
 -1.04 / -0.45%
Today’s Change
172.21
Today|||52-Week Range
239.43
+20.86%
Year-to-Date
Varian (VAR): What's in Store for the Stock in Q3 Earnings?
Jul 22 / Zacks.com - Paid Partner Content
Can Stryker (SYK) Pull an Earnings Surprise this Season?
Jul 20 / Zacks.com - Paid Partner Content
C.R. Bard (BCR) Well Poised to Beat Q2 Earnings Estimates?
Jul 21 / Zacks.com - Paid Partner Content
The Yacktman Focused Fund Sells Out of C.R. Bard Inc.
Jul 19 / GuruFocus News - Paid Partner Content
Should You Buy CR Bard (BCR) Ahead of Earnings?
Jul 21 / Zacks.com - Paid Partner Content
Will LabCorp (LH) Beat Earnings Estimates in Q2?
Jul 18 / Zacks.com - Paid Partner Content
Strong And Under The Radar: C.R. Bard (BCR)
Jul 20 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close230.00
Today’s open230.00
Day’s range228.34 - 230.00
Volume519,027
Average volume (3 months)463,840
Market cap$16.9B
Dividend yield0.45%
Data as of 4:02pm ET, 07/25/2016

Growth & Valuation

Earnings growth (last year)-52.93%
Earnings growth (this year)+11.73%
Earnings growth (next 5 years)+10.21%
Revenue growth (last year)+2.78%
P/E ratio153.7
Price/Sales4.18
Price/Book11.65

Competitors

 Today’s
change
Today’s
% change
EWEdwards Lifesciences...+0.27+0.25%
ZBHZimmer Biomet Holdin...-1.13-0.91%
DXCMDexCom Inc-0.09-0.10%
WSTWest Pharmaceutical ...-0.52-0.67%
Data as of 4:02pm ET, 07/25/2016

Financials

Last reporting dateJuly 21, 2016
EPS forecast (this quarter)$2.47
Annual revenue (last year)$3.4B
Annual profit (last year)$133.5M
Net profit margin3.91%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Tim M. Ring
President, Chief Operating Officer &
Director
John H. Weiland
Corporate headquarters
Murray Hill, New Jersey

Forecasts

Partner Offers

Search for Jobs